Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
2008-4-21
pubmed:abstractText
Matrix protein 2 (M2) of influenza A is a tetrameric type III membrane protein that functions as a proton-selective channel. The extracellular domain (M2e) has remained nearly invariable since the first human influenza strain was isolated in 1933. By linking a modified form of the leucine zipper of the yeast transcription factor GCN4 to M2e, we obtained a recombinant tetrameric protein, M2e-tGCN4. This protein mimics the quaternary structure of the ectodomain of the natural M2 protein. M2e-tGCN4 was purified, biochemically characterized, and used to immunize BALB/c mice. High M2e-specific serum IgG antibody titers were obtained following either intraperitoneal or intranasal administration. Immunized mice were protected fully against a potentially lethal influenza A virus challenge. Antibodies raised by M2e-tGCN4 immunization specifically bound to the surface of influenza-infected cells and to an M2-expressing cell line. Using a M2e peptide competition enzyme-linked immunosorbent assay with M2-expressing cells as target, we obtained evidence that M2e-tGCN4 induces antibodies that are specific for the native tetrameric M2 ectodomain. Therefore, fusion of an oligomerization domain to the extracellular part of a transmembrane protein allows it to mimic the natural quaternary structure and can promote the induction of oligomer-specific antibodies.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-10502819, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-10520648, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-12628550, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-12744898, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-12852861, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-14240539, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-15914228, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-16169634, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-16407184, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-17150104, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-17163383, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-1989386, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-2053285, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-2304147, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-3840537, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-5040386, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-5784043, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-6337877, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-6843658, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-7590329, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-8248779, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-8423445, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-851223, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-8602510, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-867833, http://linkedlifedata.com/resource/pubmed/commentcorrection/18252707-8782356
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
25
pubmed:volume
283
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
11382-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.
pubmed:affiliation
Department of Molecular Biomedical Research, Vlaams Instituut voor Biotechnologie (VIB), B9052 Ghent, Belgium.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural